

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | antibacterial humoral response (GO:0019731) | 9.86252164 |
| 2 | innate immune response in mucosa (GO:0002227) | 9.71732185 |
| 3 | antimicrobial humoral response (GO:0019730) | 9.66398144 |
| 4 | regulation of T cell tolerance induction (GO:0002664) | 9.04148947 |
| 5 | defense response to fungus (GO:0050832) | 8.56701391 |
| 6 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 8.41772016 |
| 7 | mucosal immune response (GO:0002385) | 7.91883272 |
| 8 | B cell receptor signaling pathway (GO:0050853) | 7.90729402 |
| 9 | organ or tissue specific immune response (GO:0002251) | 7.34504967 |
| 10 | antigen processing and presentation of endogenous antigen (GO:0019883) | 7.21000978 |
| 11 | production of molecular mediator involved in inflammatory response (GO:0002532) | 7.12317289 |
| 12 | intestinal epithelial cell development (GO:0060576) | 7.05420389 |
| 13 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 6.96234629 |
| 14 | cellular response to zinc ion (GO:0071294) | 6.90248471 |
| 15 | disruption of cells of other organism (GO:0044364) | 6.88740822 |
| 16 | killing of cells of other organism (GO:0031640) | 6.88740822 |
| 17 | positive regulation of tolerance induction (GO:0002645) | 6.67477653 |
| 18 | regulation of tolerance induction (GO:0002643) | 6.66089649 |
| 19 | somatic hypermutation of immunoglobulin genes (GO:0016446) | 6.59989631 |
| 20 | somatic diversification of immune receptors via somatic mutation (GO:0002566) | 6.59989631 |
| 21 | regulation of B cell receptor signaling pathway (GO:0050855) | 6.17694814 |
| 22 | positive regulation of type 2 immune response (GO:0002830) | 6.06234711 |
| 23 | response to fungus (GO:0009620) | 6.04819266 |
| 24 | iron ion import (GO:0097286) | 5.71919681 |
| 25 | response to peptidoglycan (GO:0032494) | 5.65792820 |
| 26 | branching involved in prostate gland morphogenesis (GO:0060442) | 5.55539467 |
| 27 | interferon-gamma secretion (GO:0072643) | 5.38796165 |
| 28 | chaperone mediated protein folding requiring cofactor (GO:0051085) | 5.35928076 |
| 29 | killing of cells in other organism involved in symbiotic interaction (GO:0051883) | 5.26548081 |
| 30 | disruption of cells of other organism involved in symbiotic interaction (GO:0051818) | 5.26548081 |
| 31 | positive regulation of steroid hormone secretion (GO:2000833) | 5.12612853 |
| 32 | positive thymic T cell selection (GO:0045059) | 4.91645799 |
| 33 | positive regulation of transcription from RNA polymerase III promoter (GO:0045945) | 4.88819902 |
| 34 | detection of other organism (GO:0098543) | 4.87767613 |
| 35 | negative regulation of B cell apoptotic process (GO:0002903) | 4.83752722 |
| 36 | detection of bacterium (GO:0016045) | 4.73478270 |
| 37 | mature B cell differentiation (GO:0002335) | 4.56021785 |
| 38 | negative regulation of bone mineralization (GO:0030502) | 4.55105648 |
| 39 | response to host immune response (GO:0052572) | 4.52701140 |
| 40 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 4.52701140 |
| 41 | regulation of chronic inflammatory response (GO:0002676) | 4.47698149 |
| 42 | hypotonic response (GO:0006971) | 4.41616869 |
| 43 | kynurenine metabolic process (GO:0070189) | 4.41097333 |
| 44 | regulation of B cell apoptotic process (GO:0002902) | 4.37399284 |
| 45 | peptide cross-linking (GO:0018149) | 4.37313525 |
| 46 | leukocyte migration involved in inflammatory response (GO:0002523) | 4.32620483 |
| 47 | B cell proliferation (GO:0042100) | 4.18967932 |
| 48 | keratinization (GO:0031424) | 4.17515139 |
| 49 | regulation of B cell proliferation (GO:0030888) | 4.14927609 |
| 50 | positive regulation of gamma-delta T cell activation (GO:0046645) | 4.11080429 |
| 51 | tryptophan catabolic process (GO:0006569) | 4.10924475 |
| 52 | indole-containing compound catabolic process (GO:0042436) | 4.10924475 |
| 53 | indolalkylamine catabolic process (GO:0046218) | 4.10924475 |
| 54 | negative regulation of interleukin-8 production (GO:0032717) | 4.09939483 |
| 55 | defense response to Gram-positive bacterium (GO:0050830) | 4.06648981 |
| 56 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 4.05679508 |
| 57 | response to host (GO:0075136) | 4.05679508 |
| 58 | response to host defenses (GO:0052200) | 4.05679508 |
| 59 | cellular extravasation (GO:0045123) | 4.05160951 |
| 60 | positive regulation of osteoblast proliferation (GO:0033690) | 4.03819032 |
| 61 | negative regulation of biomineral tissue development (GO:0070168) | 3.99917612 |
| 62 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.97629270 |
| 63 | negative regulation of B cell proliferation (GO:0030889) | 3.97207724 |
| 64 | regulation of superoxide anion generation (GO:0032928) | 3.93957087 |
| 65 | negative regulation of gene silencing (GO:0060969) | 3.92890107 |
| 66 | negative regulation of interleukin-10 production (GO:0032693) | 3.92343113 |
| 67 | regulation of B cell differentiation (GO:0045577) | 3.91499613 |
| 68 | negative thymic T cell selection (GO:0045060) | 3.87221350 |
| 69 | negative regulation of execution phase of apoptosis (GO:1900118) | 3.86545438 |
| 70 | regulation of germinal center formation (GO:0002634) | 3.82727499 |
| 71 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.82643848 |
| 72 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.82643848 |
| 73 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 3.77999035 |
| 74 | negative regulation of lymphocyte apoptotic process (GO:0070229) | 3.76796676 |
| 75 | purine nucleotide transport (GO:0015865) | 3.70645478 |
| 76 | prostate epithelial cord arborization involved in prostate glandular acinus morphogenesis (GO:006052 | 3.70200490 |
| 77 | mature B cell differentiation involved in immune response (GO:0002313) | 3.67700465 |
| 78 | thymic T cell selection (GO:0045061) | 3.65307215 |
| 79 | regulation of epithelial cell proliferation involved in prostate gland development (GO:0060768) | 3.64433008 |
| 80 | keratinocyte proliferation (GO:0043616) | 3.61725194 |
| 81 | intracellular estrogen receptor signaling pathway (GO:0030520) | 3.57589154 |
| 82 | oxygen transport (GO:0015671) | 3.55462367 |
| 83 | regulation of MHC class I biosynthetic process (GO:0045343) | 3.53208416 |
| 84 | positive regulation of B cell proliferation (GO:0030890) | 3.51513865 |
| 85 | sequestering of metal ion (GO:0051238) | 3.51151124 |
| 86 | hemoglobin metabolic process (GO:0020027) | 3.50256238 |
| 87 | regulation of toll-like receptor 4 signaling pathway (GO:0034143) | 3.49774110 |
| 88 | protein retention in ER lumen (GO:0006621) | 3.48807392 |
| 89 | negative T cell selection (GO:0043383) | 3.47488313 |
| 90 | positive regulation of B cell differentiation (GO:0045579) | 3.44950027 |
| 91 | negative regulation of inclusion body assembly (GO:0090084) | 3.43877995 |
| 92 | tryptophan metabolic process (GO:0006568) | 3.42899689 |
| 93 | B cell homeostasis (GO:0001782) | 3.42079090 |
| 94 | positive regulation of interleukin-12 production (GO:0032735) | 3.39807483 |
| 95 | response to phenylpropanoid (GO:0080184) | 3.39579570 |
| 96 | regulation of sequestering of triglyceride (GO:0010889) | 3.38330053 |
| 97 | germinal center formation (GO:0002467) | 3.36403486 |
| 98 | B cell activation involved in immune response (GO:0002312) | 3.35668206 |
| 99 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 3.35019578 |
| 100 | gas transport (GO:0015669) | 3.34692636 |
| 101 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 3.33700535 |
| 102 | positive regulation of antigen processing and presentation (GO:0002579) | 3.32229856 |
| 103 | keratinocyte differentiation (GO:0030216) | 3.31943498 |
| 104 | erythrocyte development (GO:0048821) | 3.31890558 |
| 105 | positive regulation of toll-like receptor signaling pathway (GO:0034123) | 3.29627810 |
| 106 | regulation of type 2 immune response (GO:0002828) | 3.29542070 |
| 107 | negative regulation of antigen receptor-mediated signaling pathway (GO:0050858) | 3.28485872 |
| 108 | negative regulation of T cell apoptotic process (GO:0070233) | 3.27962713 |
| 109 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.27069375 |
| 110 | B cell activation (GO:0042113) | 3.27010844 |
| 111 | retina homeostasis (GO:0001895) | 3.26687389 |
| 112 | lung lobe morphogenesis (GO:0060463) | 3.26669054 |
| 113 | epithelial cell maturation (GO:0002070) | 3.26605948 |
| 114 | detection of external biotic stimulus (GO:0098581) | 3.26312440 |
| 115 | multicellular organismal water homeostasis (GO:0050891) | 3.26202398 |
| 116 | water homeostasis (GO:0030104) | 3.25235269 |
| 117 | cell killing (GO:0001906) | 3.24247626 |
| 118 | positive T cell selection (GO:0043368) | 3.22578587 |
| 119 | protoporphyrinogen IX metabolic process (GO:0046501) | 3.21916638 |
| 120 | somatic diversification of immunoglobulins (GO:0016445) | 3.21750370 |
| 121 | regulation of chromatin silencing (GO:0031935) | 3.21747481 |
| 122 | antigen receptor-mediated signaling pathway (GO:0050851) | 3.21727615 |
| 123 | superoxide anion generation (GO:0042554) | 3.19657632 |
| 124 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 3.19624869 |
| 125 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 3.19153163 |
| 126 | neutrophil activation involved in immune response (GO:0002283) | 3.18585940 |
| 127 | neutrophil activation (GO:0042119) | 3.17639542 |
| 128 | positive regulation of macrophage cytokine production (GO:0060907) | 3.15858568 |
| 129 | histamine secretion (GO:0001821) | 3.12519506 |
| 130 | lymph node development (GO:0048535) | 3.12375889 |
| 131 | peptidyl-proline hydroxylation (GO:0019511) | 3.12290910 |
| 132 | import into cell (GO:0098657) | 3.11293000 |
| 133 | regulation of natural killer cell differentiation (GO:0032823) | 3.11096430 |
| 134 | regulation of steroid hormone secretion (GO:2000831) | 3.10746344 |
| 135 | negative regulation of potassium ion transmembrane transport (GO:1901380) | 3.10721156 |
| 136 | establishment of endothelial barrier (GO:0061028) | 3.09910415 |
| 137 | complement activation, classical pathway (GO:0006958) | 3.08760417 |
| 138 | immunoglobulin mediated immune response (GO:0016064) | 3.08158671 |
| 139 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 3.07623588 |
| 140 | negative regulation of leukocyte apoptotic process (GO:2000107) | 3.07504884 |
| 141 | defense response to bacterium (GO:0042742) | 3.07079697 |
| 142 | positive regulation of interferon-gamma biosynthetic process (GO:0045078) | 3.06617968 |
| 143 | negative regulation of growth of symbiont in host (GO:0044130) | 3.03744468 |
| 144 | negative regulation of growth of symbiont involved in interaction with host (GO:0044146) | 3.03744468 |
| 145 | modulation of growth of symbiont involved in interaction with host (GO:0044144) | 3.03744468 |
| 146 | regulation of growth of symbiont in host (GO:0044126) | 3.03744468 |
| 147 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.02568952 |
| 148 | regulation of lipopolysaccharide-mediated signaling pathway (GO:0031664) | 3.01117985 |
| 149 | somatic diversification of immunoglobulins involved in immune response (GO:0002208) | 2.99150344 |
| 150 | isotype switching (GO:0045190) | 2.99150344 |
| 151 | somatic recombination of immunoglobulin genes involved in immune response (GO:0002204) | 2.99150344 |
| 152 | positive regulation of interferon-alpha production (GO:0032727) | 2.96106589 |
| 153 | lymphocyte homeostasis (GO:0002260) | 2.95026344 |
| 154 | immune response-activating cell surface receptor signaling pathway (GO:0002429) | 2.94928388 |
| 155 | leukocyte aggregation (GO:0070486) | 2.94373243 |
| 156 | biotin metabolic process (GO:0006768) | 2.94194104 |
| 157 | positive regulation of interleukin-2 production (GO:0032743) | 2.93865761 |
| 158 | prostate gland epithelium morphogenesis (GO:0060740) | 2.93266067 |
| 159 | B cell mediated immunity (GO:0019724) | 2.91476906 |
| 160 | cellular response to ethanol (GO:0071361) | 2.90439697 |
| 161 | positive regulation of gene expression, epigenetic (GO:0045815) | 2.87841722 |
| 162 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 2.87403866 |
| 163 | T cell selection (GO:0045058) | 2.87321563 |
| 164 | regulation of receptor binding (GO:1900120) | 2.86494279 |
| 165 | granulocyte activation (GO:0036230) | 2.82341159 |
| 166 | positive regulation of Rap GTPase activity (GO:0032854) | 2.80202789 |
| 167 | positive regulation of B cell activation (GO:0050871) | 2.79183984 |
| 168 | myeloid cell development (GO:0061515) | 2.79170288 |
| 169 | regulation of female gonad development (GO:2000194) | 2.78530629 |
| 170 | protoporphyrinogen IX biosynthetic process (GO:0006782) | 2.77132972 |
| 171 | regulation of B cell activation (GO:0050864) | 2.76789275 |
| 172 | citrulline biosynthetic process (GO:0019240) | 2.74584981 |
| 173 | response to bacterium (GO:0009617) | 2.73888122 |
| 174 | regulation of chemokine secretion (GO:0090196) | 2.73392590 |
| 175 | regulation of interferon-alpha production (GO:0032647) | 2.72703066 |
| 176 | detection of biotic stimulus (GO:0009595) | 2.72244141 |
| 177 | regulation of gamma-delta T cell activation (GO:0046643) | 2.72166942 |
| 178 | epidermal cell differentiation (GO:0009913) | 2.72055397 |
| 179 | regulation of macrophage cytokine production (GO:0010935) | 2.69728678 |
| 180 | histone H3-K9 demethylation (GO:0033169) | 2.64524865 |
| 181 | intracellular steroid hormone receptor signaling pathway (GO:0030518) | 2.64013124 |
| 182 | cellular response to interleukin-6 (GO:0071354) | 2.61718056 |
| 183 | COPI coating of Golgi vesicle (GO:0048205) | 2.60925004 |
| 184 | Golgi transport vesicle coating (GO:0048200) | 2.60925004 |
| 185 | parturition (GO:0007567) | 2.59667999 |
| 186 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.59429053 |
| 187 | positive regulation of transcription from RNA polymerase II promoter in response to stress (GO:00360 | 2.58592117 |
| 188 | phagosome maturation (GO:0090382) | 2.55954385 |
| 189 | response to testosterone (GO:0033574) | 2.55242083 |
| 190 | mitotic cell cycle arrest (GO:0071850) | 2.55028183 |
| 191 | androgen receptor signaling pathway (GO:0030521) | 2.54998477 |
| 192 | regulation of transcription from RNA polymerase II promoter in response to oxidative stress (GO:0043 | 2.54314842 |
| 193 | chemical homeostasis within a tissue (GO:0048875) | 2.52168160 |
| 194 | cytidine metabolic process (GO:0046087) | 10.4216067 |
| 195 | cytidine catabolic process (GO:0006216) | 10.4216067 |
| 196 | cytidine deamination (GO:0009972) | 10.4216067 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 7.85480012 |
| 2 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 7.07050043 |
| 3 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 5.21342646 |
| 4 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 4.80949695 |
| 5 | MYC_22102868_ChIP-Seq_BL_Human | 3.96550504 |
| 6 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 3.52877499 |
| 7 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 3.51291014 |
| 8 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.46415110 |
| 9 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.40702815 |
| 10 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 3.09253983 |
| 11 | RUNX_20019798_ChIP-Seq_JUKART_Human | 3.05536243 |
| 12 | AR_21909140_ChIP-Seq_LNCAP_Human | 2.89799920 |
| 13 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.81464856 |
| 14 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 2.74615318 |
| 15 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 2.73210281 |
| 16 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 2.64733634 |
| 17 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.59883482 |
| 18 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.54403386 |
| 19 | MAF_26560356_Chip-Seq_TH1_Human | 2.48344549 |
| 20 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.42874034 |
| 21 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 2.39255624 |
| 22 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 2.38337947 |
| 23 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.37912559 |
| 24 | * PIAS1_25552417_ChIP-Seq_VCAP_Human | 2.37563564 |
| 25 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 2.37537785 |
| 26 | MYB_26560356_Chip-Seq_TH1_Human | 2.36856498 |
| 27 | GATA1_22025678_ChIP-Seq_K562_Human | 2.33678620 |
| 28 | * FOXA1_25552417_ChIP-Seq_VCAP_Human | 2.31363313 |
| 29 | MYB_26560356_Chip-Seq_TH2_Human | 2.28130346 |
| 30 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 2.27924781 |
| 31 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 2.26102327 |
| 32 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.24082972 |
| 33 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 2.19815837 |
| 34 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 2.19491473 |
| 35 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.08165745 |
| 36 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 2.05913445 |
| 37 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.98760414 |
| 38 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.98480179 |
| 39 | GATA1_19941826_ChIP-Seq_K562_Human | 1.97116524 |
| 40 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.95627971 |
| 41 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.89625004 |
| 42 | CHD1_26751641_Chip-Seq_LNCaP_Human | 1.84394113 |
| 43 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.83783592 |
| 44 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.83579584 |
| 45 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.80011907 |
| 46 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 1.72910315 |
| 47 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 1.72910315 |
| 48 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 1.72910315 |
| 49 | UTX_26944678_Chip-Seq_JUKART_Human | 1.70638871 |
| 50 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.68928112 |
| 51 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.68207209 |
| 52 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 1.62153353 |
| 53 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.60987347 |
| 54 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 1.60712537 |
| 55 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.58719486 |
| 56 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.57770895 |
| 57 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.57341617 |
| 58 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.53915802 |
| 59 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.52008179 |
| 60 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.46674429 |
| 61 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.46636074 |
| 62 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.46480255 |
| 63 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.46089005 |
| 64 | GATA3_26560356_Chip-Seq_TH1_Human | 1.44410204 |
| 65 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.42768274 |
| 66 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.42756285 |
| 67 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.39192175 |
| 68 | E2F7_22180533_ChIP-Seq_HELA_Human | 1.37815402 |
| 69 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.37434803 |
| 70 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.37188036 |
| 71 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.37127712 |
| 72 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.36959370 |
| 73 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.36251754 |
| 74 | MAF_26560356_Chip-Seq_TH2_Human | 1.35737295 |
| 75 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.35511340 |
| 76 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 1.30976781 |
| 77 | RXR_22108803_ChIP-Seq_LS180_Human | 1.30061639 |
| 78 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.29443358 |
| 79 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.28295785 |
| 80 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.27077990 |
| 81 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.26427665 |
| 82 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.25114957 |
| 83 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.23924771 |
| 84 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.23909333 |
| 85 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.22811704 |
| 86 | SPI1_23127762_ChIP-Seq_K562_Human | 1.21397140 |
| 87 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.21262268 |
| 88 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.19151559 |
| 89 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.17890857 |
| 90 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.17434441 |
| 91 | * GATA4_25053715_ChIP-Seq_YYC3_Human | 1.17176895 |
| 92 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.16271106 |
| 93 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.15501863 |
| 94 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.15092124 |
| 95 | ZIC3_20872845_ChIP-ChIP_MESCs_Mouse | 1.13625309 |
| 96 | FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 1.11777087 |
| 97 | EGR1_19032775_ChIP-ChIP_M12_Human | 1.11337837 |
| 98 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.10937866 |
| 99 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.10922906 |
| 100 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.09598999 |
| 101 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.08948929 |
| 102 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.08514035 |
| 103 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.07905558 |
| 104 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.06485181 |
| 105 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.04934870 |
| 106 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.04441825 |
| 107 | GATA3_26560356_Chip-Seq_TH2_Human | 1.04326914 |
| 108 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.02861844 |
| 109 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.02036643 |
| 110 | GATA6_25053715_ChIP-Seq_YYC3_Human | 1.01134721 |
| 111 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.99418845 |
| 112 | SMRT_27268052_Chip-Seq_Bcells_Human | 0.99303724 |
| 113 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.98982523 |
| 114 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 0.97979374 |
| 115 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.97734281 |
| 116 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 0.97612804 |
| 117 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 0.95739975 |
| 118 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 0.95739975 |
| 119 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.93261102 |
| 120 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.91426580 |
| 121 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.91426580 |
| 122 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.91248500 |
| 123 | OCT1_27270436_Chip-Seq_PROSTATE_Human | 0.90577500 |
| 124 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.89859777 |
| 125 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.87342639 |
| 126 | SOX11_23321250_ChIP-ChIP_Z138-A519-JVM2_Human | 0.85886787 |
| 127 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 0.85340578 |
| 128 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.83472906 |
| 129 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.82334684 |
| 130 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 0.82014039 |
| 131 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.79907561 |
| 132 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.76480407 |
| 133 | CLOCK_20551151_ChIP-Seq_293T_Human | 0.76154319 |
| 134 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 0.76028954 |
| 135 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 0.74623659 |
| 136 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.74504486 |
| 137 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 0.74070309 |
| 138 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.71269118 |
| 139 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 0.71042500 |
| 140 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.70879658 |
| 141 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 0.69771944 |
| 142 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.69618253 |
| 143 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.69526341 |
| 144 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 0.69490294 |
| 145 | ELF5_23300383_ChIP-Seq_T47D_Human | 0.69396508 |
| 146 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.68862127 |
| 147 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.67450319 |
| 148 | * GATA2_19941826_ChIP-Seq_K562_Human | 0.67038047 |
| 149 | AR_21572438_ChIP-Seq_LNCaP_Human | 0.66791652 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002009_preneoplasia | 8.45536111 |
| 2 | MP0001835_abnormal_antigen_presentation | 5.25458139 |
| 3 | MP0000537_abnormal_urethra_morphology | 4.87523869 |
| 4 | MP0001800_abnormal_humoral_immune | 4.64648514 |
| 5 | MP0005387_immune_system_phenotype | 4.56248762 |
| 6 | MP0001790_abnormal_immune_system | 4.56248762 |
| 7 | MP0002452_abnormal_antigen_presenting | 3.50203178 |
| 8 | MP0003303_peritoneal_inflammation | 3.47868660 |
| 9 | MP0003315_abnormal_perineum_morphology | 3.39658440 |
| 10 | MP0000685_abnormal_immune_system | 3.08145754 |
| 11 | MP0005000_abnormal_immune_tolerance | 2.97432678 |
| 12 | MP0004145_abnormal_muscle_electrophysio | 2.97107739 |
| 13 | MP0002723_abnormal_immune_serum | 2.87002437 |
| 14 | MP0002420_abnormal_adaptive_immunity | 2.69241619 |
| 15 | MP0001819_abnormal_immune_cell | 2.64287413 |
| 16 | MP0002254_reproductive_system_inflammat | 2.50476218 |
| 17 | MP0003300_gastrointestinal_ulcer | 2.39761016 |
| 18 | MP0005671_abnormal_response_to | 2.37494335 |
| 19 | MP0002398_abnormal_bone_marrow | 2.37103400 |
| 20 | MP0001346_abnormal_lacrimal_gland | 2.32869077 |
| 21 | MP0002148_abnormal_hypersensitivity_rea | 2.28108020 |
| 22 | MP0000716_abnormal_immune_system | 2.28074712 |
| 23 | MP0004510_myositis | 2.12734945 |
| 24 | MP0001853_heart_inflammation | 2.11196216 |
| 25 | MP0000689_abnormal_spleen_morphology | 2.06667361 |
| 26 | MP0005636_abnormal_mineral_homeostasis | 2.04523767 |
| 27 | MP0003656_abnormal_erythrocyte_physiolo | 2.02936802 |
| 28 | MP0000003_abnormal_adipose_tissue | 1.97173714 |
| 29 | MP0000465_gastrointestinal_hemorrhage | 1.97004001 |
| 30 | MP0002933_joint_inflammation | 1.92994254 |
| 31 | MP0001765_abnormal_ion_homeostasis | 1.91984190 |
| 32 | MP0003763_abnormal_thymus_physiology | 1.90560385 |
| 33 | MP0004043_abnormal_pH_regulation | 1.90527295 |
| 34 | MP0001756_abnormal_urination | 1.84240053 |
| 35 | MP0003646_muscle_fatigue | 1.82026783 |
| 36 | MP0004264_abnormal_extraembryonic_tissu | 1.80583575 |
| 37 | MP0010386_abnormal_urinary_bladder | 1.80321491 |
| 38 | MP0004947_skin_inflammation | 1.78130989 |
| 39 | MP0002429_abnormal_blood_cell | 1.76262560 |
| 40 | MP0002722_abnormal_immune_system | 1.73627223 |
| 41 | MP0003941_abnormal_skin_development | 1.72609765 |
| 42 | MP0005025_abnormal_response_to | 1.69869479 |
| 43 | MP0003436_decreased_susceptibility_to | 1.65874364 |
| 44 | MP0000013_abnormal_adipose_tissue | 1.65437551 |
| 45 | MP0002419_abnormal_innate_immunity | 1.63319025 |
| 46 | MP0002971_abnormal_brown_adipose | 1.63303742 |
| 47 | MP0002006_tumorigenesis | 1.61151883 |
| 48 | MP0002796_impaired_skin_barrier | 1.59366945 |
| 49 | MP0001533_abnormal_skeleton_physiology | 1.59165572 |
| 50 | MP0008004_abnormal_stomach_pH | 1.55206111 |
| 51 | MP0001845_abnormal_inflammatory_respons | 1.54679380 |
| 52 | MP0001873_stomach_inflammation | 1.53771774 |
| 53 | MP0004036_abnormal_muscle_relaxation | 1.50178560 |
| 54 | MP0005076_abnormal_cell_differentiation | 1.49181218 |
| 55 | MP0005310_abnormal_salivary_gland | 1.46291324 |
| 56 | MP0005275_abnormal_skin_tensile | 1.43591283 |
| 57 | MP0000538_abnormal_urinary_bladder | 1.40848584 |
| 58 | MP0002405_respiratory_system_inflammati | 1.40758636 |
| 59 | MP0003183_abnormal_peptide_metabolism | 1.38985407 |
| 60 | MP0003191_abnormal_cellular_cholesterol | 1.38635542 |
| 61 | MP0009785_altered_susceptibility_to | 1.36208228 |
| 62 | MP0002166_altered_tumor_susceptibility | 1.34937959 |
| 63 | MP0002160_abnormal_reproductive_system | 1.29557237 |
| 64 | MP0008961_abnormal_basal_metabolism | 1.28681871 |
| 65 | MP0010155_abnormal_intestine_physiology | 1.28647440 |
| 66 | MP0005647_abnormal_sex_gland | 1.27896455 |
| 67 | MP0003045_fibrosis | 1.26695878 |
| 68 | MP0002234_abnormal_pharynx_morphology | 1.24052590 |
| 69 | MP0009764_decreased_sensitivity_to | 1.22412464 |
| 70 | MP0003566_abnormal_cell_adhesion | 1.20012988 |
| 71 | MP0004185_abnormal_adipocyte_glucose | 1.19968481 |
| 72 | MP0005375_adipose_tissue_phenotype | 1.18005497 |
| 73 | MP0005451_abnormal_body_composition | 1.13813757 |
| 74 | MP0000703_abnormal_thymus_morphology | 1.12193866 |
| 75 | MP0003866_abnormal_defecation | 1.11481143 |
| 76 | MP0000566_synostosis | 1.08779293 |
| 77 | MP0001919_abnormal_reproductive_system | 1.08199183 |
| 78 | MP0010234_abnormal_vibrissa_follicle | 1.06812458 |
| 79 | MP0003195_calcinosis | 1.04153850 |
| 80 | MP0003868_abnormal_feces_composition | 1.03353694 |
| 81 | MP0002896_abnormal_bone_mineralization | 1.02053493 |
| 82 | MP0005389_reproductive_system_phenotype | 1.00192145 |
| 83 | MP0004130_abnormal_muscle_cell | 0.99238039 |
| 84 | MP0002138_abnormal_hepatobiliary_system | 0.97997150 |
| 85 | MP0002019_abnormal_tumor_incidence | 0.95830793 |
| 86 | MP0008057_abnormal_DNA_replication | 0.95398369 |
| 87 | MP0000613_abnormal_salivary_gland | 0.94416629 |
| 88 | MP0002168_other_aberrant_phenotype | 0.94182544 |
| 89 | MP0005164_abnormal_response_to | 0.93667794 |
| 90 | MP0002136_abnormal_kidney_physiology | 0.92980792 |
| 91 | MP0005501_abnormal_skin_physiology | 0.88284804 |
| 92 | MP0005248_abnormal_Harderian_gland | 0.87706283 |
| 93 | MP0003448_altered_tumor_morphology | 0.87197745 |
| 94 | MP0005464_abnormal_platelet_physiology | 0.86207060 |
| 95 | MP0004808_abnormal_hematopoietic_stem | 0.84969033 |
| 96 | MP0010352_gastrointestinal_tract_polyps | 0.84404782 |
| 97 | MP0008260_abnormal_autophagy | 0.84343080 |
| 98 | MP0001881_abnormal_mammary_gland | 0.83816127 |
| 99 | MP0004019_abnormal_vitamin_homeostasis | 0.81796968 |
| 100 | MP0006036_abnormal_mitochondrial_physio | 0.81268307 |
| 101 | MP0009643_abnormal_urine_homeostasis | 0.81146280 |
| 102 | MP0005379_endocrine/exocrine_gland_phen | 0.80282641 |
| 103 | MP0005666_abnormal_adipose_tissue | 0.78774663 |
| 104 | MP0001191_abnormal_skin_condition | 0.78337448 |
| 105 | MP0008469_abnormal_protein_level | 0.77066777 |
| 106 | MP0003453_abnormal_keratinocyte_physiol | 0.76949333 |
| 107 | MP0009931_abnormal_skin_appearance | 0.76175598 |
| 108 | MP0010678_abnormal_skin_adnexa | 0.75734654 |
| 109 | MP0002693_abnormal_pancreas_physiology | 0.74595870 |
| 110 | MP0002060_abnormal_skin_morphology | 0.74292116 |
| 111 | MP0008874_decreased_physiological_sensi | 0.74273041 |
| 112 | MP0002132_abnormal_respiratory_system | 0.73606653 |
| 113 | MP0000627_abnormal_mammary_gland | 0.72920362 |
| 114 | MP0004883_abnormal_blood_vessel | 0.72697041 |
| 115 | MP0001666_abnormal_nutrient_absorption | 0.72619468 |
| 116 | MP0003828_pulmonary_edema | 0.72254392 |
| 117 | MP0003075_altered_response_to | 0.72225252 |
| 118 | MP0000467_abnormal_esophagus_morphology | 0.72084936 |
| 119 | MP0005187_abnormal_penis_morphology | 0.70923335 |
| 120 | MP0003690_abnormal_glial_cell | 0.70872074 |
| 121 | MP0005503_abnormal_tendon_morphology | 0.69499643 |
| 122 | MP0001879_abnormal_lymphatic_vessel | 0.69468682 |
| 123 | MP0005535_abnormal_body_temperature | 0.69317712 |
| 124 | MP0005397_hematopoietic_system_phenotyp | 0.68981974 |
| 125 | MP0001545_abnormal_hematopoietic_system | 0.68981974 |
| 126 | MP0003221_abnormal_cardiomyocyte_apopto | 0.68888905 |
| 127 | MP0003787_abnormal_imprinting | 0.68523263 |
| 128 | MP0000747_muscle_weakness | 0.68195688 |
| 129 | MP0009115_abnormal_fat_cell | 0.66637471 |
| 130 | MP0004858_abnormal_nervous_system | 0.66597957 |
| 131 | MP0005390_skeleton_phenotype | 0.66496103 |
| 132 | MP0004147_increased_porphyrin_level | 0.66123596 |
| 133 | MP0005083_abnormal_biliary_tract | 0.66079197 |
| 134 | MP0006054_spinal_hemorrhage | 0.65365361 |
| 135 | MP0002970_abnormal_white_adipose | 0.65209441 |
| 136 | MP0001727_abnormal_embryo_implantation | 0.64806522 |
| 137 | MP0000609_abnormal_liver_physiology | 0.64597160 |
| 138 | MP0004957_abnormal_blastocyst_morpholog | 0.63237003 |
| 139 | MP0005166_decreased_susceptibility_to | 0.63164868 |
| 140 | MP0003091_abnormal_cell_migration | 0.63054202 |
| 141 | MP0001851_eye_inflammation | 0.61251031 |
| 142 | MP0009765_abnormal_xenobiotic_induced | 0.60677148 |
| 143 | MP0002108_abnormal_muscle_morphology | 0.60396346 |
| 144 | MP0000490_abnormal_crypts_of | 0.59243308 |
| 145 | MP0003724_increased_susceptibility_to | 0.58638137 |
| 146 | MP0002396_abnormal_hematopoietic_system | 0.58464320 |
| 147 | MP0001216_abnormal_epidermal_layer | 0.58335655 |
| 148 | MP0003795_abnormal_bone_structure | 0.57750134 |
| 149 | MP0005220_abnormal_exocrine_pancreas | 0.56810872 |
| 150 | MP0010094_abnormal_chromosome_stability | 0.56453559 |
| 151 | MP0000681_abnormal_thyroid_gland | 0.55774270 |
| 152 | MP0005621_abnormal_cell_physiology | 0.55342948 |
| 153 | MP0004484_altered_response_of | 0.54984612 |
| 154 | MP0002098_abnormal_vibrissa_morphology | 0.53227547 |
| 155 | MP0000377_abnormal_hair_follicle | 0.50234395 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Hyperactive renin-angiotensin system (HP:0000841) | 8.72206993 |
| 2 | Gastrointestinal stroma tumor (HP:0100723) | 8.44040746 |
| 3 | Decreased circulating renin level (HP:0003351) | 8.20728049 |
| 4 | Recurrent bronchitis (HP:0002837) | 6.85198417 |
| 5 | Recurrent sinusitis (HP:0011108) | 6.77665106 |
| 6 | Cellulitis (HP:0100658) | 6.05429463 |
| 7 | Hyperkalemia (HP:0002153) | 5.95856599 |
| 8 | Prostate neoplasm (HP:0100787) | 5.76773963 |
| 9 | Chronic bronchitis (HP:0004469) | 5.71058895 |
| 10 | Colitis (HP:0002583) | 5.66721870 |
| 11 | Testicular atrophy (HP:0000029) | 5.54654463 |
| 12 | Abnormality of secondary sexual hair (HP:0009888) | 5.51638433 |
| 13 | Abnormality of the axillary hair (HP:0100134) | 5.51638433 |
| 14 | Papilloma (HP:0012740) | 5.35952787 |
| 15 | Verrucae (HP:0200043) | 5.35952787 |
| 16 | Chronic otitis media (HP:0000389) | 5.31314258 |
| 17 | Hypokalemic alkalosis (HP:0001949) | 5.31095642 |
| 18 | Calf muscle hypertrophy (HP:0008981) | 5.29846108 |
| 19 | Chronic sinusitis (HP:0011109) | 5.28219037 |
| 20 | Gonadotropin excess (HP:0000837) | 5.22496794 |
| 21 | Lymphopenia (HP:0001888) | 4.94988713 |
| 22 | Lip pit (HP:0100267) | 4.94195039 |
| 23 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 4.85358342 |
| 24 | Recurrent lower respiratory tract infections (HP:0002783) | 4.63894309 |
| 25 | Muscle hypertrophy of the lower extremities (HP:0008968) | 4.63067893 |
| 26 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 4.58143133 |
| 27 | IgM deficiency (HP:0002850) | 4.54209073 |
| 28 | IgA deficiency (HP:0002720) | 4.51292020 |
| 29 | Inflammation of the large intestine (HP:0002037) | 4.50145264 |
| 30 | Emphysema (HP:0002097) | 4.39834543 |
| 31 | Abnormality of renin-angiotensin system (HP:0000847) | 4.24353795 |
| 32 | Hyperaldosteronism (HP:0000859) | 4.21870255 |
| 33 | Renal salt wasting (HP:0000127) | 4.21782693 |
| 34 | Gastrointestinal inflammation (HP:0004386) | 4.20816398 |
| 35 | Recurrent otitis media (HP:0000403) | 4.19788243 |
| 36 | Hyponatremia (HP:0002902) | 4.15451924 |
| 37 | Hypochromic microcytic anemia (HP:0004840) | 4.13695039 |
| 38 | Meningitis (HP:0001287) | 4.07718546 |
| 39 | Bronchitis (HP:0012387) | 4.07567569 |
| 40 | Recurrent pneumonia (HP:0006532) | 4.00868461 |
| 41 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 3.93512469 |
| 42 | Osteomyelitis (HP:0002754) | 3.92048362 |
| 43 | IgG deficiency (HP:0004315) | 3.85894611 |
| 44 | Flat acetabular roof (HP:0003180) | 3.81157259 |
| 45 | Vasculitis (HP:0002633) | 3.80872690 |
| 46 | Recurrent viral infections (HP:0004429) | 3.80870746 |
| 47 | Panhypogammaglobulinemia (HP:0003139) | 3.66700439 |
| 48 | Testicular neoplasm (HP:0010788) | 3.64668577 |
| 49 | Abnormality of sodium homeostasis (HP:0010931) | 3.63489667 |
| 50 | Autoimmune thrombocytopenia (HP:0001973) | 3.56781979 |
| 51 | Small epiphyses (HP:0010585) | 3.52577983 |
| 52 | Recurrent cutaneous fungal infections (HP:0011370) | 3.46692834 |
| 53 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.46692834 |
| 54 | Restrictive lung disease (HP:0002091) | 3.40314541 |
| 55 | Azoospermia (HP:0000027) | 3.15331657 |
| 56 | Viral hepatitis (HP:0006562) | 3.15189294 |
| 57 | Sepsis (HP:0100806) | 3.10789240 |
| 58 | Bifid scrotum (HP:0000048) | 2.93227165 |
| 59 | Recurrent abscess formation (HP:0002722) | 2.89387449 |
| 60 | Recurrent fungal infections (HP:0002841) | 2.82319819 |
| 61 | Recurrent skin infections (HP:0001581) | 2.73617815 |
| 62 | Abnormality of T cell physiology (HP:0011840) | 2.70418229 |
| 63 | Flattened epiphyses (HP:0003071) | 2.69628017 |
| 64 | Skin rash (HP:0000988) | 2.67810818 |
| 65 | Stomach cancer (HP:0012126) | 2.66321602 |
| 66 | Recurrent bacterial skin infections (HP:0005406) | 2.63605410 |
| 67 | Abnormal hemoglobin (HP:0011902) | 2.62610186 |
| 68 | Absent hair (HP:0002298) | 2.62579195 |
| 69 | Abnormality of male internal genitalia (HP:0000022) | 2.54821613 |
| 70 | Abnormality of small intestinal villus morphology (HP:0011472) | 2.54289741 |
| 71 | Villous atrophy (HP:0011473) | 2.54289741 |
| 72 | Alkalosis (HP:0001948) | 2.51676571 |
| 73 | Hypokalemia (HP:0002900) | 2.49265653 |
| 74 | Poikilocytosis (HP:0004447) | 2.48485529 |
| 75 | Abnormality of the fingertips (HP:0001211) | 2.45734995 |
| 76 | Increased IgE level (HP:0003212) | 2.44959710 |
| 77 | Xerostomia (HP:0000217) | 2.43830701 |
| 78 | Stenosis of the external auditory canal (HP:0000402) | 2.39704684 |
| 79 | Bulbar palsy (HP:0001283) | 2.39252752 |
| 80 | Adrenal overactivity (HP:0002717) | 2.37267670 |
| 81 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.36600248 |
| 82 | Oral leukoplakia (HP:0002745) | 2.34809889 |
| 83 | Nasal polyposis (HP:0100582) | 2.34669944 |
| 84 | Lymphoma (HP:0002665) | 2.32677598 |
| 85 | Leukopenia (HP:0001882) | 2.31841620 |
| 86 | Autoimmune hemolytic anemia (HP:0001890) | 2.29409686 |
| 87 | Abnormal spermatogenesis (HP:0008669) | 2.25577080 |
| 88 | Mediastinal lymphadenopathy (HP:0100721) | 2.25028851 |
| 89 | Abnormality of the distal phalanx of the thumb (HP:0009617) | 2.24433083 |
| 90 | Mitral stenosis (HP:0001718) | 2.24191171 |
| 91 | Thyroiditis (HP:0100646) | 2.20263925 |
| 92 | B lymphocytopenia (HP:0010976) | 2.20220112 |
| 93 | Abnormality of B cell number (HP:0010975) | 2.20220112 |
| 94 | Abnormality of potassium homeostasis (HP:0011042) | 2.18568074 |
| 95 | Popliteal pterygium (HP:0009756) | 2.18216641 |
| 96 | Limb hypertonia (HP:0002509) | 2.18029010 |
| 97 | Abnormality of chloride homeostasis (HP:0011422) | 2.17735905 |
| 98 | Myocardial infarction (HP:0001658) | 2.17012646 |
| 99 | Renal cortical cysts (HP:0000803) | 2.16414840 |
| 100 | Urticaria (HP:0001025) | 2.15898823 |
| 101 | Neutropenia (HP:0001875) | 2.14893560 |
| 102 | Abnormal cartilage morphology (HP:0002763) | 2.14682380 |
| 103 | Abnormality of T cells (HP:0002843) | 2.14113789 |
| 104 | Hypotension (HP:0002615) | 2.13388341 |
| 105 | Skin ulcer (HP:0200042) | 2.13211016 |
| 106 | Eczematoid dermatitis (HP:0000976) | 2.12122601 |
| 107 | Papilledema (HP:0001085) | 2.11322632 |
| 108 | Polycythemia (HP:0001901) | 2.10639420 |
| 109 | Oligomenorrhea (HP:0000876) | 2.10051344 |
| 110 | Microcytic anemia (HP:0001935) | 2.09581738 |
| 111 | Encephalitis (HP:0002383) | 2.04509890 |
| 112 | Vertebral arch anomaly (HP:0008438) | 2.02265404 |
| 113 | Sparse lateral eyebrow (HP:0005338) | 2.02082151 |
| 114 | Agammaglobulinemia (HP:0004432) | 10.0910855 |
| 115 | Ulnar bowing (HP:0003031) | 1.99186348 |
| 116 | Septate vagina (HP:0001153) | 1.99183177 |
| 117 | Irregular vertebral endplates (HP:0003301) | 1.97841641 |
| 118 | Short 1st metacarpal (HP:0010034) | 1.96495104 |
| 119 | Aplasia/Hypoplasia of the 1st metacarpal (HP:0010026) | 1.96495104 |
| 120 | Abnormality of T cell number (HP:0011839) | 1.95302489 |
| 121 | Gingivitis (HP:0000230) | 1.94432423 |
| 122 | Abnormality of carpal bone ossification (HP:0006257) | 1.93478606 |
| 123 | Chronic diarrhea (HP:0002028) | 1.92996081 |
| 124 | Hypochromic anemia (HP:0001931) | 1.92526892 |
| 125 | Abnormality of the salivary glands (HP:0010286) | 1.91194781 |
| 126 | Abnormality of the 1st metacarpal (HP:0010009) | 1.89648560 |
| 127 | Abnormality of the prostate (HP:0008775) | 1.89443395 |
| 128 | Cystic hygroma (HP:0000476) | 1.88302301 |
| 129 | Visceral angiomatosis (HP:0100761) | 1.88104376 |
| 130 | Curly hair (HP:0002212) | 1.87827247 |
| 131 | Gastrointestinal infarctions (HP:0005244) | 1.84078748 |
| 132 | Abnormality of the nasal mucosa (HP:0000433) | 1.83430463 |
| 133 | Hyperpituitarism (HP:0010514) | 1.82164705 |
| 134 | Dehydration (HP:0001944) | 1.81992071 |
| 135 | Abnormality of cells of the erythroid lineage (HP:0012130) | 1.81749507 |
| 136 | Hemangiomatosis (HP:0007461) | 1.79602235 |
| 137 | Limited elbow extension (HP:0001377) | 1.78147108 |
| 138 | Recurrent gram-negative bacterial infections (HP:0005420) | 1.77217631 |
| 139 | Primary adrenal insufficiency (HP:0008207) | 1.76794831 |
| 140 | Tibial bowing (HP:0002982) | 1.76452818 |
| 141 | Abnormal foot bone ossification (HP:0010675) | 1.75517299 |
| 142 | Interstitial pulmonary disease (HP:0006530) | 1.75271540 |
| 143 | Neonatal hypoglycemia (HP:0001998) | 1.74861692 |
| 144 | Hepatitis (HP:0012115) | 1.73127790 |
| 145 | Abnormality of the calf musculature (HP:0001430) | 1.72048343 |
| 146 | Systemic lupus erythematosus (HP:0002725) | 1.71869884 |
| 147 | Abnormal tarsal ossification (HP:0008369) | 1.64481799 |
| 148 | Arthralgia (HP:0002829) | 1.64174834 |
| 149 | Prolonged bleeding time (HP:0003010) | 1.63100366 |
| 150 | Bronchiectasis (HP:0002110) | 1.63032279 |
| 151 | Papillary thyroid carcinoma (HP:0002895) | 1.62641674 |
| 152 | Volvulus (HP:0002580) | 1.62206257 |
| 153 | Hypoplasia of the capital femoral epiphysis (HP:0003090) | 1.61769799 |
| 154 | Eosinophilia (HP:0001880) | 1.61270481 |
| 155 | Pustule (HP:0200039) | 1.58628638 |
| 156 | Glomerulonephritis (HP:0000099) | 1.58622023 |
| 157 | Anhidrosis (HP:0000970) | 1.57432071 |
| 158 | Metaphyseal cupping (HP:0003021) | 1.57071822 |
| 159 | Thrombocytosis (HP:0001894) | 1.56596411 |
| 160 | Cupped ribs (HP:0000887) | 1.56303960 |
| 161 | Aortic aneurysm (HP:0004942) | 1.56293453 |
| 162 | Deep philtrum (HP:0002002) | 1.56010931 |
| 163 | Multiple enchondromatosis (HP:0005701) | 1.55041267 |
| 164 | Chronic obstructive pulmonary disease (HP:0006510) | 1.54327953 |
| 165 | Obstructive lung disease (HP:0006536) | 1.54327953 |
| 166 | Menorrhagia (HP:0000132) | 1.54205645 |
| 167 | Short phalanx of the thumb (HP:0009660) | 1.53588347 |
| 168 | Seborrheic dermatitis (HP:0001051) | 1.53202719 |
| 169 | Camptodactyly of toe (HP:0001836) | 1.51955717 |
| 170 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 1.50634436 |
| 171 | Polygenic inheritance (HP:0010982) | 1.49206854 |
| 172 | Congenital ichthyosiform erythroderma (HP:0007431) | 1.48413321 |
| 173 | Cerebral ischemia (HP:0002637) | 1.47641418 |
| 174 | Ventricular fibrillation (HP:0001663) | 1.46819865 |
| 175 | Thickened nuchal skin fold (HP:0000474) | 1.46598778 |
| 176 | Hypoplasia of the uterus (HP:0000013) | 1.45781988 |
| 177 | Abnormality of nail color (HP:0100643) | 1.45219479 |
| 178 | Abnormality of the parathyroid morphology (HP:0011766) | 1.43818721 |
| 179 | Paralysis (HP:0003470) | 1.43017603 |
| 180 | Abnormality of macrophages (HP:0004311) | 1.42614675 |
| 181 | Flat capital femoral epiphysis (HP:0003370) | 1.42598030 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TNK2 | 7.02438644 |
| 2 | MAP4K1 | 6.01100606 |
| 3 | MST4 | 4.30020090 |
| 4 | FER | 3.88658227 |
| 5 | CAMK1D | 3.73702772 |
| 6 | GRK6 | 3.27151695 |
| 7 | TAOK1 | 3.12495919 |
| 8 | SYK | 2.85440989 |
| 9 | WNK4 | 2.82696799 |
| 10 | CAMK1G | 2.74819863 |
| 11 | BLK | 2.61881543 |
| 12 | LRRK2 | 2.61300720 |
| 13 | STK10 | 2.59084877 |
| 14 | PRKCH | 2.55936640 |
| 15 | ERN1 | 2.54622976 |
| 16 | CSF1R | 2.53914373 |
| 17 | STK39 | 2.23329550 |
| 18 | BTK | 2.21322964 |
| 19 | TEC | 1.98039364 |
| 20 | MAP3K14 | 1.85098467 |
| 21 | PRKCQ | 1.79302615 |
| 22 | RIPK4 | 1.77750439 |
| 23 | MAP2K3 | 1.76504348 |
| 24 | LYN | 1.73960986 |
| 25 | RPS6KA4 | 1.72106321 |
| 26 | KIT | 1.71557291 |
| 27 | NEK9 | 1.68901604 |
| 28 | EIF2AK3 | 1.68124465 |
| 29 | ITK | 1.63854309 |
| 30 | AKT3 | 1.62879972 |
| 31 | PRPF4B | 1.61624261 |
| 32 | MAP3K6 | 1.57890373 |
| 33 | YES1 | 1.55334018 |
| 34 | LATS1 | 1.48590203 |
| 35 | GRK1 | 1.48261155 |
| 36 | MAP3K13 | 1.47752320 |
| 37 | JAK1 | 1.47132589 |
| 38 | MAPKAPK5 | 1.44879595 |
| 39 | PDK2 | 1.44019432 |
| 40 | MARK2 | 1.35025407 |
| 41 | TBK1 | 1.33045440 |
| 42 | CSK | 1.31976506 |
| 43 | MAP3K7 | 1.21892735 |
| 44 | IRAK1 | 1.19224797 |
| 45 | CLK1 | 1.15889390 |
| 46 | TYK2 | 1.15351936 |
| 47 | MAPK15 | 1.14804392 |
| 48 | MAP3K10 | 1.11875445 |
| 49 | EPHB1 | 1.11133486 |
| 50 | IKBKB | 1.09058429 |
| 51 | RPS6KB2 | 1.08875509 |
| 52 | PKN2 | 1.07346927 |
| 53 | TRPM7 | 1.06670088 |
| 54 | PRKCI | 1.05943995 |
| 55 | ALK | 1.05873249 |
| 56 | HCK | 1.05474895 |
| 57 | NLK | 1.04681555 |
| 58 | FES | 1.04115258 |
| 59 | STK3 | 1.03212138 |
| 60 | SGK3 | 1.03150574 |
| 61 | PRKAA2 | 1.01256893 |
| 62 | MAP3K2 | 0.95205354 |
| 63 | CSNK1A1L | 0.93547620 |
| 64 | STK24 | 0.93400882 |
| 65 | PRKD2 | 0.93324296 |
| 66 | IKBKE | 0.92613038 |
| 67 | RET | 0.92365646 |
| 68 | SGK2 | 0.91083302 |
| 69 | TSSK6 | 0.89383415 |
| 70 | KSR2 | 0.87131591 |
| 71 | TESK1 | 0.86525280 |
| 72 | MAP3K5 | 0.86466248 |
| 73 | EPHA3 | 0.85719677 |
| 74 | CSNK1G1 | 0.83048247 |
| 75 | TAOK3 | 0.82456956 |
| 76 | SGK494 | 0.82211868 |
| 77 | SGK223 | 0.82211868 |
| 78 | BRSK2 | 0.81433517 |
| 79 | TGFBR2 | 0.80288935 |
| 80 | RAF1 | 0.79824730 |
| 81 | LCK | 0.78682243 |
| 82 | HIPK2 | 0.77194971 |
| 83 | MATK | 0.75568788 |
| 84 | PRKD3 | 0.74956732 |
| 85 | ABL1 | 0.73870190 |
| 86 | MAPKAPK3 | 0.72858437 |
| 87 | CDK7 | 0.72490143 |
| 88 | IRAK2 | 0.71988570 |
| 89 | CDC42BPA | 0.71971096 |
| 90 | ZAP70 | 0.69657162 |
| 91 | FGFR2 | 0.69289814 |
| 92 | SIK2 | 0.67512817 |
| 93 | INSR | 0.67278432 |
| 94 | CDK12 | 0.66457008 |
| 95 | CHUK | 0.66340614 |
| 96 | CSNK1G3 | 0.65804393 |
| 97 | NEK6 | 0.65701411 |
| 98 | PLK4 | 0.63967225 |
| 99 | JAK3 | 0.62892394 |
| 100 | IRAK4 | 0.61533519 |
| 101 | MARK3 | 0.60544219 |
| 102 | MAPKAPK2 | 0.60089812 |
| 103 | PDPK1 | 0.59597241 |
| 104 | FYN | 0.59518712 |
| 105 | PRKCD | 0.58677526 |
| 106 | MAP3K1 | 0.55450920 |
| 107 | SGK1 | 0.54604367 |
| 108 | PLK2 | 0.53530032 |
| 109 | CAMKK2 | 0.52875317 |
| 110 | FRK | 0.52472581 |
| 111 | SCYL2 | 0.52448029 |
| 112 | FGFR3 | 0.52125450 |
| 113 | EEF2K | 0.51994368 |
| 114 | FGFR4 | 0.50847685 |
| 115 | MAP3K3 | 0.50484104 |
| 116 | FGR | 0.50398097 |
| 117 | PDK1 | 0.49168590 |
| 118 | PAK2 | 0.48703064 |
| 119 | PTK6 | 0.48021668 |
| 120 | IRAK3 | 0.46762866 |
| 121 | CDK4 | 0.45969771 |
| 122 | OXSR1 | 0.45775186 |
| 123 | CDK3 | 0.44575610 |
| 124 | EPHA2 | 0.43459723 |
| 125 | BCR | 0.43390451 |
| 126 | DAPK2 | 0.43344466 |
| 127 | TAOK2 | 0.43315681 |
| 128 | PDK3 | 0.42815420 |
| 129 | PDK4 | 0.42815420 |
| 130 | NUAK1 | 0.42345830 |
| 131 | PIM1 | 0.42034729 |
| 132 | JAK2 | 0.41548805 |
| 133 | SIK1 | 0.41119922 |
| 134 | PIK3CG | 0.40027911 |
| 135 | MTOR | 0.39271895 |
| 136 | DYRK3 | 0.37515867 |
| 137 | MAPK12 | 0.37484012 |
| 138 | CSNK1G2 | 0.37047858 |
| 139 | BRD4 | 0.36470217 |
| 140 | MELK | 0.35479476 |
| 141 | PDGFRA | 0.35471962 |
| 142 | PRKAA1 | 0.35211493 |
| 143 | TRIB3 | 0.34259217 |
| 144 | AKT2 | 0.34127441 |
| 145 | PIK3CA | 0.33922384 |
| 146 | CSNK1D | 0.33844060 |
| 147 | RPS6KA6 | 0.32963095 |
| 148 | RPS6KC1 | 0.32684739 |
| 149 | RPS6KL1 | 0.32684739 |
| 150 | WNK1 | 0.32661607 |
| 151 | CDK9 | 0.31895526 |
| 152 | PDGFRB | 0.30456957 |
| 153 | ERBB3 | 0.29909156 |
| 154 | BCKDK | 0.29647125 |
| 155 | MAPK4 | 0.28481133 |
| 156 | ILK | 0.27237776 |
| 157 | BMPR2 | 0.26855273 |
| 158 | MAP2K4 | 0.25238685 |
| 159 | PRKCZ | 0.24857688 |
| 160 | AKT1 | 0.21287123 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary immunodeficiency_Homo sapiens_hsa05340 | 7.31723837 |
| 2 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 6.20258492 |
| 3 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 3.80944492 |
| 4 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 3.77210220 |
| 5 | African trypanosomiasis_Homo sapiens_hsa05143 | 3.27397074 |
| 6 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 2.89701303 |
| 7 | Prostate cancer_Homo sapiens_hsa05215 | 2.75850221 |
| 8 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.67041464 |
| 9 | Antigen processing and presentation_Homo sapiens_hsa04612 | 2.65852146 |
| 10 | ABC transporters_Homo sapiens_hsa02010 | 2.48294605 |
| 11 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 2.43467775 |
| 12 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.99205192 |
| 13 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.92360264 |
| 14 | mTOR signaling pathway_Homo sapiens_hsa04150 | 1.89457604 |
| 15 | Mineral absorption_Homo sapiens_hsa04978 | 1.67595572 |
| 16 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.65355369 |
| 17 | Malaria_Homo sapiens_hsa05144 | 1.62264638 |
| 18 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.59380958 |
| 19 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.55723445 |
| 20 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.53039848 |
| 21 | Base excision repair_Homo sapiens_hsa03410 | 1.52746402 |
| 22 | Leishmaniasis_Homo sapiens_hsa05140 | 1.43306282 |
| 23 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 1.43049185 |
| 24 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.42696686 |
| 25 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.41952795 |
| 26 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.38771726 |
| 27 | Viral myocarditis_Homo sapiens_hsa05416 | 1.38716718 |
| 28 | Pancreatic secretion_Homo sapiens_hsa04972 | 1.38093891 |
| 29 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.35240188 |
| 30 | Insulin signaling pathway_Homo sapiens_hsa04910 | 1.28701225 |
| 31 | Renin-angiotensin system_Homo sapiens_hsa04614 | 1.27483608 |
| 32 | Tuberculosis_Homo sapiens_hsa05152 | 1.25129920 |
| 33 | Platelet activation_Homo sapiens_hsa04611 | 1.24342078 |
| 34 | Amoebiasis_Homo sapiens_hsa05146 | 1.21831484 |
| 35 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 1.21378188 |
| 36 | Mismatch repair_Homo sapiens_hsa03430 | 1.16756788 |
| 37 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.14527793 |
| 38 | Apoptosis_Homo sapiens_hsa04210 | 1.12873791 |
| 39 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.11121451 |
| 40 | Endometrial cancer_Homo sapiens_hsa05213 | 1.10294713 |
| 41 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 1.06788157 |
| 42 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.05026484 |
| 43 | Circadian rhythm_Homo sapiens_hsa04710 | 1.03538145 |
| 44 | Influenza A_Homo sapiens_hsa05164 | 1.03476366 |
| 45 | Ribosome_Homo sapiens_hsa03010 | 1.01200436 |
| 46 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.00110503 |
| 47 | Hepatitis B_Homo sapiens_hsa05161 | 0.98315465 |
| 48 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.97117819 |
| 49 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.96707774 |
| 50 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.91969512 |
| 51 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.91747388 |
| 52 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.91627786 |
| 53 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.91087147 |
| 54 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.89958271 |
| 55 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.89449568 |
| 56 | Measles_Homo sapiens_hsa05162 | 0.87399345 |
| 57 | HTLV-I infection_Homo sapiens_hsa05166 | 0.84147392 |
| 58 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.83568027 |
| 59 | DNA replication_Homo sapiens_hsa03030 | 0.82060244 |
| 60 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.81699106 |
| 61 | Glioma_Homo sapiens_hsa05214 | 0.77817491 |
| 62 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.76860321 |
| 63 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.75128380 |
| 64 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.74596809 |
| 65 | Bladder cancer_Homo sapiens_hsa05219 | 0.73152613 |
| 66 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.72834194 |
| 67 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.69902266 |
| 68 | Thyroid cancer_Homo sapiens_hsa05216 | 0.68225441 |
| 69 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.68221184 |
| 70 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.65698388 |
| 71 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.64169555 |
| 72 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.63124519 |
| 73 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.61446814 |
| 74 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.60598080 |
| 75 | Adherens junction_Homo sapiens_hsa04520 | 0.59960714 |
| 76 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.59368354 |
| 77 | Endocytosis_Homo sapiens_hsa04144 | 0.58780623 |
| 78 | Shigellosis_Homo sapiens_hsa05131 | 0.58557536 |
| 79 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.57944020 |
| 80 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.57030831 |
| 81 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.56954225 |
| 82 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.56647592 |
| 83 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.56521892 |
| 84 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.56254047 |
| 85 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.55476144 |
| 86 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.55155399 |
| 87 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.54899161 |
| 88 | Legionellosis_Homo sapiens_hsa05134 | 0.54117204 |
| 89 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.51387503 |
| 90 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.50554671 |
| 91 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.50515397 |
| 92 | Focal adhesion_Homo sapiens_hsa04510 | 0.49210016 |
| 93 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.49007815 |
| 94 | Insulin resistance_Homo sapiens_hsa04931 | 0.47983391 |
| 95 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.47754048 |
| 96 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.47482842 |
| 97 | Hepatitis C_Homo sapiens_hsa05160 | 0.46808410 |
| 98 | Salivary secretion_Homo sapiens_hsa04970 | 0.46447711 |
| 99 | Pathways in cancer_Homo sapiens_hsa05200 | 0.46137336 |
| 100 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.45006174 |
| 101 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.44781502 |
| 102 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.44768369 |
| 103 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.43875285 |
| 104 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.42734935 |
| 105 | Melanoma_Homo sapiens_hsa05218 | 0.42594253 |
| 106 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.42022852 |
| 107 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.41759943 |
| 108 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.41499787 |
| 109 | Histidine metabolism_Homo sapiens_hsa00340 | 0.40706351 |
| 110 | Allograft rejection_Homo sapiens_hsa05330 | 0.40674227 |
| 111 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.39832525 |
| 112 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.39237386 |
| 113 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.39173364 |
| 114 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.38711770 |
| 115 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.38640410 |
| 116 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.37845283 |
| 117 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.37110866 |
| 118 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.37078762 |
| 119 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.36819010 |
| 120 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.36711768 |
| 121 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.36445827 |
| 122 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.35769010 |
| 123 | Salmonella infection_Homo sapiens_hsa05132 | 0.35300951 |
| 124 | Colorectal cancer_Homo sapiens_hsa05210 | 0.34974155 |
| 125 | Pertussis_Homo sapiens_hsa05133 | 0.34285669 |
| 126 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.34172280 |
| 127 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.34083668 |
| 128 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.32490912 |
| 129 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.31801715 |
| 130 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.31787956 |
| 131 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.31771841 |
| 132 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.31746707 |
| 133 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.31577056 |
| 134 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.31440286 |
| 135 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.31423197 |
| 136 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.30425983 |
| 137 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.29684743 |
| 138 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.28684858 |
| 139 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.28454321 |
| 140 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.27036047 |

